Paolo La Colla

6.9k total citations
173 papers, 5.9k citations indexed

About

Paolo La Colla is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Paolo La Colla has authored 173 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Organic Chemistry, 90 papers in Infectious Diseases and 56 papers in Molecular Biology. Recurrent topics in Paolo La Colla's work include HIV/AIDS drug development and treatment (86 papers), HIV Research and Treatment (49 papers) and Synthesis and Biological Evaluation (39 papers). Paolo La Colla is often cited by papers focused on HIV/AIDS drug development and treatment (86 papers), HIV Research and Treatment (49 papers) and Synthesis and Biological Evaluation (39 papers). Paolo La Colla collaborates with scholars based in Italy, Denmark and Poland. Paolo La Colla's co-authors include Roberta Loddo, Marino Artico, Silvio Massa, Anna Giulia Loi, Giuseppina Sanna, Matteo Incerti, Paola Vicini, Enzo Tramontano, Romano Silvestri and Alessandra Pani and has published in prestigious journals such as Biochemistry, Chemosphere and Biophysical Journal.

In The Last Decade

Paolo La Colla

172 papers receiving 5.7k citations

Peers

Paolo La Colla
Paolo La Colla
Citations per year, relative to Paolo La Colla Paolo La Colla (= 1×) peers Stefano Aquaro

Countries citing papers authored by Paolo La Colla

Since Specialization
Citations

This map shows the geographic impact of Paolo La Colla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo La Colla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo La Colla more than expected).

Fields of papers citing papers by Paolo La Colla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo La Colla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo La Colla. The network helps show where Paolo La Colla may publish in the future.

Co-authorship network of co-authors of Paolo La Colla

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo La Colla. A scholar is included among the top collaborators of Paolo La Colla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo La Colla. Paolo La Colla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pedersen, Erik B., et al.. (2016). Synthesis and Anti‐HIV‐1 Evaluation of Some Novel MC‐1220 Analogs as Non‐Nucleoside Reverse Transcriptase Inhibitors. Archiv der Pharmazie. 349(5). 363–372. 6 indexed citations
2.
Briguglio, Irene, Roberta Loddo, Erik Laurini, et al.. (2015). Synthesis, cytotoxicity and antiviral evaluation of new series of imidazo[4,5-g]quinoline and pyrido[2,3-g]quinoxalinone derivatives. European Journal of Medicinal Chemistry. 105. 63–79. 37 indexed citations
3.
Fobofou, Serge A. T., Katrin Franke, Giuseppina Sanna, et al.. (2015). Isolation and anticancer, anthelminthic, and antiviral (HIV) activity of acylphloroglucinols, and regioselective synthesis of empetrifranzinans from Hypericum roeperianum. Bioorganic & Medicinal Chemistry. 23(19). 6327–6334. 44 indexed citations
4.
Mandas, Antonella, Claudia Abete, Paolo Putzu, et al.. (2012). Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients. Lipids in Health and Disease. 11(1). 39–39. 30 indexed citations
5.
Loddo, Roberta, Sophia G. Antimisiaris, Ulrike Sauermann, et al.. (2011). Topical Nonnucleoside Reverse Transcriptase Inhibitor MC 1220 Partially Prevents Vaginal RT-SHIV Infection of Macaques. AIDS Research and Human Retroviruses. 27(9). 933–943. 16 indexed citations
6.
Vascellari, Sarah, Sebastiano Banni, C. Vacca, et al.. (2011). Accumulation and aberrant composition of cholesteryl esters in Scrapie-infected N2a cells and C57BL/6 mouse brains. Lipids in Health and Disease. 10(1). 132–132. 6 indexed citations
7.
Caron, Mélanie, Guillaume Besson, Spyridon Mourtas, et al.. (2010). Protective properties of non-nucleoside reverse transcriptase inhibitor (MC1220) incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIV. Virology. 405(1). 225–233. 43 indexed citations
8.
Boryski, Jerzy, Jacek Stawiński, Adam Kraszewski, et al.. (2009). Aryl nucleoside H-phosphonates. Part 16: Synthesis and anti-HIV-1 activity of di-aryl nucleoside phosphotriesters. Bioorganic & Medicinal Chemistry. 17(9). 3489–3498. 18 indexed citations
9.
El‐Brollosy, Nasser R., Omar A. Al‐Deeb, Ali A. El‐Emam, et al.. (2009). Synthesis of Novel Uracil Non‐Nucleoside Derivatives as Potential Reverse Transcriptase Inhibitors of HIV‐1. Archiv der Pharmazie. 342(11). 663–670. 23 indexed citations
10.
Balbi, Alessandro, et al.. (2009). Antiviral activity of indole derivatives. Antiviral Research. 83(2). 179–185. 56 indexed citations
11.
Vicini, Paola, Matteo Incerti, Paolo La Colla, & Roberta Loddo. (2008). Anti-HIV evaluation of benzo[d]isothiazole hydrazones. European Journal of Medicinal Chemistry. 44(4). 1801–1807. 89 indexed citations
12.
Tonelli, Michele, Giuseppe Paglietti, Vito Boido, et al.. (2008). Antiviral Activity of Benzimidazole Derivatives. I. Antiviral Activity of 1‐Substituted‐2‐[(Benzotriazol‐1/2‐yl)methyl]benzimidazoles. Chemistry & Biodiversity. 5(11). 2386–2401. 73 indexed citations
13.
Loddo, Roberta, et al.. (2007). SYNTHESIS AND IN VITRO ANTIVIRAL STUDIES OF BIS (PIVALOYLOXYMETHYL) ESTER DERIVATIVE OF 9-{((PHOSPHONOMETHYL) AZIRIDIN-1-YL)METHYL} ADENINE (PMAMA) AND ANALOGUES. Saudi Pharmaceutical Journal. 15(1). 16–22. 1 indexed citations
14.
Carta, Antonio, Giovanni Loriga, Sandra Piras, et al.. (2006). Synthesis and In Vitro Evaluation of the Anti-Viral Activity of N-[4-(1H(2H)-benzotriazol-1(2)-yl)phenyl]alkylcarboxamides. Medicinal Chemistry. 2(6). 577–589. 44 indexed citations
15.
16.
Mai, Antonello, Marino Artico, Rino Ragno, et al.. (2005). 5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family. Bioorganic & Medicinal Chemistry. 13(6). 2065–2077. 42 indexed citations
17.
Sbardella, Gianluca, et al.. (2004). Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480. Bioorganic & Medicinal Chemistry Letters. 14(6). 1537–1541. 53 indexed citations
18.
Vicini, Paola, et al.. (2003). Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases. Bioorganic & Medicinal Chemistry. 11(22). 4785–4789. 291 indexed citations
19.
Aiello, Enrico, Stefania Aiello, Francesco Mingoia, et al.. (2000). Synthesis and antimicrobial activity of new 3-(1-R-3(5)-methyl-4-nitroso-1H-5(3)-pyrazolyl)-5-methylisoxazoles. Bioorganic & Medicinal Chemistry. 8(12). 2719–2728. 24 indexed citations
20.
Menozzi, Giulia, Luisa Mosti, Olga Bruno, et al.. (1999). Synthesis and biological evaluation of [α-(1,5-disubstituted 1H-pyrazol-4-yl)benzyl]azoles, analogues of bifonazole. Il Farmaco. 54(6). 416–422. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026